ALB and type 2 diabetes mellitus: Indeed, our observation that in aspirin-treated patients the coexistence of low albumin levels significantly impairs the clinical efficacy of aspirin, suggests a new mechanism potentially contributing to the aspirin resistance in patients with T2DM (Figure 2).